DIAN Diagnostics
(China stock market code: 300244) has been appointed as the Official Exclusive
Supplier of health testing related services for the 19th Asian Games
and the 4th Asian Para Games in Hangzhou 2022.
As a comprehensive
medical diagnostics service provider, DIAN Diagnostics established 40 chain
laboratories and served 20 thousand+ medical institutions and over 460 million
people. To fulfil the mission of achieving "Equal Access to
Healthcare". DIAN Diagnostics is committed to play an active role in
COVID-19 diagnosis and outbreak prevention with its accumulated over 25 years`
experience in healthcare industry.
In abroad, DIAN
Biotechnology (brand: GENEDIAN), an innovative IVD company and wholly owned
subsidiary of DIAN Diagnostics, is providing integrated solutions to combat
SARS-CoV-2 with COVID-19 Antigen Rapid Test Cassette, both Professional Use and
Self-Testing, as well as Real Time PCR Detection systems for worldwide health
concerns.
https://www.dianbiotech.com